Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Molecular Therapy Oncolytics
|
June 18, 2021
Palmitoylated antigens for the induction of anti-tumor CD8<sup>+</sup> T cells and enhanced tumor recognition
Dorian A Stolk, Sophie K Horrevorts, Sjoerd T T Schetters, et al.
Plos Neglected Tropical Diseases
|
December 12, 2022
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
Wilma A Stolk, Luc E Coffeng, Fatorma K Bolay, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 31, 2019
The Fold-in, Fold-out Design for DCE Choice Tasks: Application to Burden of Disease
Lucas M A Goossens, Marcel F Jonker, Maureen P M H Rutten-van Mölken, et al.
Gates Open Research
|
February 17, 2022
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
Jessica Clark, Wilma A Stolk, María-Gloria Basáñez, et al.
BMJ Open
|
December 29, 2017
ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs
Lucas M A Goossens, Maureen P M H Rutten-van Mölken, Melinde R S Boland, et al.
Plos Neglected Tropical Diseases
|
March 14, 2018
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
Edeltraud J Lenk, William K Redekop, Marianne Luyendijk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2019
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
Edeltraud J Lenk, Henri C Moungui, Michel Boussinesq, et al.
The New England Journal of Medicine
|
November 9, 2017
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas
Joseph Kamgno, Sébastien D Pion, Cédric B Chesnais, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy
Joaquin M Prada, Panayiota Touloupou, Biruck Kebede, et al.
Cancers
|
August 31, 2019
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
Sophie K Horrevorts, Dorian A Stolk, Rieneke van de Ven, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Molecular Therapy Oncolytics
|
June 18, 2021
Palmitoylated antigens for the induction of anti-tumor CD8<sup>+</sup> T cells and enhanced tumor recognition
Dorian A Stolk, Sophie K Horrevorts, Sjoerd T T Schetters, et al.
Plos Neglected Tropical Diseases
|
December 12, 2022
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
Wilma A Stolk, Luc E Coffeng, Fatorma K Bolay, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 31, 2019
The Fold-in, Fold-out Design for DCE Choice Tasks: Application to Burden of Disease
Lucas M A Goossens, Marcel F Jonker, Maureen P M H Rutten-van Mölken, et al.
Gates Open Research
|
February 17, 2022
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
Jessica Clark, Wilma A Stolk, María-Gloria Basáñez, et al.
BMJ Open
|
December 29, 2017
ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs
Lucas M A Goossens, Maureen P M H Rutten-van Mölken, Melinde R S Boland, et al.
Plos Neglected Tropical Diseases
|
March 14, 2018
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
Edeltraud J Lenk, William K Redekop, Marianne Luyendijk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2019
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
Edeltraud J Lenk, Henri C Moungui, Michel Boussinesq, et al.
The New England Journal of Medicine
|
November 9, 2017
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas
Joseph Kamgno, Sébastien D Pion, Cédric B Chesnais, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy
Joaquin M Prada, Panayiota Touloupou, Biruck Kebede, et al.
Cancers
|
August 31, 2019
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
Sophie K Horrevorts, Dorian A Stolk, Rieneke van de Ven, et al.
Page
of 17